Startup profile · funding coverage
Inner Logic funding, valuation and investors
Simulation and testing platform for surgical and procedural medical devices — Hopkins-founded.
Keep track of Inner Logic
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$11.5M · July 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$12M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Baltimore, MD
Investors in latest funding
Lead: General Catalyst
Overview
Inner Logic (formerly Semaphor Surgical) builds simulation infrastructure for testing surgical and procedural devices. Founded in 2023 by Johns Hopkins-affiliated CEO Tito Porras, MD, CTO Mathias Unberath, PhD, and Chief Robotics Officer Axel Krieger, PhD, the Baltimore company closed an $11.5M seed in July 2026 co-led by General Catalyst and Bison Ventures with J2VP, Defined, PTX, Valia, Page One, Alumni Ventures, and Flare participating.
Why Inner Logic is interesting
Baltimore surgical-device infra: $11.5M seed (Jul 2026) co-led by General Catalyst and Bison Ventures for a Hopkins trio (Porras, Unberath, Krieger) building digital twins before first-in-human trials — rare seed size for med-device simulation.
Product & use cases
Digital simulation and validation platform for surgical and procedural medical devices.
- Preclinical device testing and design iteration
- Regulatory evidence generation for procedural tools
- Robotics-assisted procedure simulation
Key facts
- Baltimore HQ; Johns Hopkins founding team
- Seed (Jul 2026): $11.5M co-led by General Catalyst and Bison Ventures
- Simulation/testing wedge for procedural devices before clinical trials
Funding history (newest first)
Investors in our directory
Funds linked from Inner Logic's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Hopkins computer-vision and robotics depth applied to device V&V — sells to OEMs and startups needing faster iteration loops.
-
ANSYS/medical simulation incumbents incumbent
Broad engineering simulation; Inner Logic procedural-device focused.
-
In-house hospital labs adjacent
Manual cadaver/bench testing; slower iteration.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Inner Logic's financing or category context.
FAQs about Inner Logic
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.